{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:46:02Z","timestamp":1794642362604,"version":"4.9.1"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:p>\n                    Sclerosing epithelioid fibrosarcoma (SEF) is an aggressive soft tissue sarcoma, characterized by a distinctive epithelioid phenotype in a densely sclerotic collagenous stroma, that shows frequent MUC4 immunoreactivity and recurrent gene fusions, often involving\n                    <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>\n                    gene. A pathogenetic link with low-grade fibromyxoid sarcoma (LGFMS) has been suggested, due to cases with hybrid morphology as well as overlapping genetic signature. However, a small subset of SEF is negative for MUC4 and lacks the canonical\n                    <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>\n                    \/\n                    <jats:italic toggle=\"yes\">FUS<\/jats:italic>\n                    gene rearrangements. Triggered by the identification of recurrent\n                    <jats:italic toggle=\"yes\">YAP1<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">KMT2A<\/jats:italic>\n                    gene fusions by RNA sequencing in 3 index cases of MUC4-negative,\n                    <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>\n                    \/\n                    <jats:italic toggle=\"yes\">FUS<\/jats:italic>\n                    fusion-negative SEF, we further investigated a cohort of 14 similar SEF cases (MUC4-negative,\n                    <jats:italic toggle=\"yes\">EWSR1<\/jats:italic>\n                    \/\n                    <jats:italic toggle=\"yes\">FUS<\/jats:italic>\n                    fusion-negative) by fluorescence in situ hybridization (FISH), reverse transcription-polymerase chain reaction, and\/or DNA-based massively parallel sequencing (MSK-IMPACT) for abnormalities in these genes. Three additional SEFs with\n                    <jats:italic toggle=\"yes\">KMT2A<\/jats:italic>\n                    gene rearrangements and one additional case with\n                    <jats:italic toggle=\"yes\">YAP1<\/jats:italic>\n                    gene rearrangements were identified by FISH. In addition, one case with\n                    <jats:italic toggle=\"yes\">YAP1<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">KMT2A<\/jats:italic>\n                    and one with\n                    <jats:italic toggle=\"yes\">KMT2A<\/jats:italic>\n                    -\n                    <jats:italic toggle=\"yes\">YAP1<\/jats:italic>\n                    fusion were detected by reverse transcription-polymerase chain reaction and MSK-IMPACT, respectively. As a control group, 24 fibromyxoid spindle cell tumors, diagnosed or suspected as fusion-negative LGFMS, were also tested for\n                    <jats:italic toggle=\"yes\">YAP1<\/jats:italic>\n                    and\n                    <jats:italic toggle=\"yes\">KMT2A<\/jats:italic>\n                    abnormalities by FISH, but none were positive. The\n                    <jats:italic toggle=\"yes\">YAP1<\/jats:italic>\n                    \/\n                    <jats:italic toggle=\"yes\">KMT2A<\/jats:italic>\n                    -rearranged SEF group affected patients ranging from 10 to 86 years old (average and median: 45) of both sexes (4 females, 5 males). The tumors involved somatic soft tissues with a wide distribution, including extremities, trunk, neck, and dura. Histologically, the tumors showed variable cellularity, with monotonous ovoid to epithelioid tumor cells and hyalinized collagenous background typical of SEF. More than half of the cases showed infiltrative borders, within fat or skeletal muscle. No LGFMS component was identified. All tumors were negative for MUC4 and had an otherwise nonspecific immunophenotype. Of the 6 cases with available follow-up information, 2 had local recurrences, and 2 developed soft tissue and\/or bone metastases, including 1 of them died of the disease.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000001382","type":"journal-article","created":{"date-parts":[[2019,10,7]],"date-time":"2019-10-07T16:20:13Z","timestamp":1570465213000},"page":"368-377","source":"Crossref","is-referenced-by-count":91,"title":["Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Yu-Chien","family":"Kao","sequence":"first","affiliation":[{"name":"Department of Pathology, Shuang Ho Hospital, Taipei Medical University"},{"name":"Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Chieh","family":"Lee","sequence":"additional","affiliation":[{"name":"Department and Graduate Institute of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Shao","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Swanson","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Han","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Joint Biobank, Office of Human Research, Taipei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ru","family":"Liu","sequence":"additional","affiliation":[{"name":"Joint Biobank, Office of Human Research, Taipei Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narasimhan P.","family":"Agaram","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Ying","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Anatomical Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan C.","family":"Dickson","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina R.","family":"Antonescu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/00000478-199509000-00001","article-title":"Sclerosing epithelioid fibrosarcoma. A variant of fibrosarcoma simulating carcinoma","volume":"19","author":"Meis-Kindblom","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00000478-200106000-00001","article-title":"Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor","volume":"25","author":"Antonescu","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/PAS.0b013e318210c268","article-title":"MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma","volume":"35","author":"Doyle","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/PAS.0b013e3182562bf8","article-title":"MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement","volume":"36","author":"Doyle","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/PAS.0000000000000158","article-title":"Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma","volume":"38","author":"Arbajian","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/gcc.22215","article-title":"A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF\/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases","volume":"54","author":"Prieto-Granada","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"R7-20230922","doi-asserted-by":"crossref","DOI":"10.1111\/his.13926","article-title":"KMT2A (MLL) fusions in aggressive sarcomas in young adults","author":"Yoshida","year":"2019","journal-title":"Histopathology"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12885-017-3368-4","article-title":"First case of B ALL with KMT2A-MAML2 rearrangement: a case report","volume":"17","author":"Menu","year":"2017","journal-title":"BMC Cancer"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/leu.2008.50","article-title":"Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemia","volume":"22","author":"Metzler","year":"2008","journal-title":"Leukemia"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/gcc.20467","article-title":"Identification of a novel fusion gene MLL-MAML2 in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23)","volume":"46","author":"Nemoto","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1172\/JCI126185","article-title":"Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma","volume":"130","author":"Sekine","year":"2019","journal-title":"J Clin Invest"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1101\/gr.156224.113","article-title":"Discovery of recurrent structural variants in nasopharyngeal carcinoma","volume":"24","author":"Valouev","year":"2014","journal-title":"Genome Res"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.celrep.2018.10.096","article-title":"Integrated genomic, epigenomic, and expression analyses of ovarian cancer cell lines","volume":"25","author":"Papp","year":"2018","journal-title":"Cell Rep"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/s41467-019-09940-1","article-title":"Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening","volume":"10","author":"Picco","year":"2019","journal-title":"Nat Commun"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/ajcp\/88.5.615","article-title":"Low-grade fibromyxoid sarcoma. A report of two metastasizing neoplasms having a deceptively benign appearance","volume":"88","author":"Evans","year":"1987","journal-title":"Am J Clin Pathol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00000478-199306000-00007","article-title":"Low-grade fibromyxoid sarcoma. A report of 12 cases","volume":"17","author":"Evans","year":"1993","journal-title":"Am J Surg Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/PAS.0b013e31822b3687","article-title":"Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up","volume":"35","author":"Evans","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1158\/1078-0432.CCR-11-0145","article-title":"FUS-CREB3L2\/L1-positive sarcomas show a specific gene expression profile with upregulation of CD24 and FOXL1","volume":"17","author":"Moller","year":"2011","journal-title":"Clin Cancer Res"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/his.12422","article-title":"MUC 4-negative FUS-CREB3L2 rearranged low-grade fibromyxoid sarcoma","volume":"65","author":"Linos","year":"2014","journal-title":"Histopathology"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/path.5053","article-title":"Transcriptomic definition of molecular subgroups of small round cell sarcomas","volume":"245","author":"Watson","year":"2018","journal-title":"J Pathol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL recombinome of acute leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/sj.leu.2401578","article-title":"Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias","volume":"13","author":"Lawrence","year":"1999","journal-title":"Leukemia"},{"key":"R23-20230922","article-title":"A dural-based spindle cell neoplasm characterized by a novel MN1-KMT2A fusion gene","author":"Chen","year":"2019","journal-title":"Neuro Oncol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/gcc.22073","article-title":"Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma","volume":"52","author":"Antonescu","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11060-018-2767-y","article-title":"C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin","volume":"138","author":"Malgulwar","year":"2018","journal-title":"J Neurooncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T18:50:17Z","timestamp":1695408617000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001382","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10,4]]}}}